Rehabilitation by Effort for Patients With Advanced Bronc... | NCT03684486

Studies
Rehabilitation by Effort for Patients With Advanced Bronchial Cancer

NCT03684486

Sponsor

University Hospital, Toulouse

Status

Terminated

Last Update Posted

May 6, 2026Actual

Enrollment

19Actual

Phase

Not Applicable

Conditions

Bronchial Cancer
Malignant Mesothelioma

Interventions

rehabilitation by effort

Countries

France

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Apr 2026

Overall Recruitment Status or Expanded Access Status

Terminated

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

recruitment difficulties

Expanded Access Info

Start Date

Feb 1, 2012Actual

Primary Completion Date

Jul 24, 2019Actual

Completion Date

Jul 24, 2019Actual

First Submitted Date

Sep 24, 2018

First Submission Date that Met QC Criteria

Sep 24, 2018

First Posted Date

Sep 25, 2018Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Apr 29, 2026

Last Update Posted Date

May 6, 2026Actual

Oversight Module

Has Data Monitoring Committee (DMC)

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

Bronchopulmonary cancers or mesothelioma are associated with effort deconditioning due to pathology (chronic inflammation) and also to treatments (surgery, radiotherapy, chemotherapy); it's considerably alters patients quality of life.

Investigators want to ensured the feasibility of rehabilitation by effort for these patients.

Detailed Description

Not provided

Design Module

Study Type

Interventional

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Not provided

Target Follow-Up Duration

Not provided

Phases

Not Applicable

Interventional Study Design

Allocation

Biospecimen

No data available

No data is available for this block.

Enrollment

19Actual

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
rehabilitation by effort	Experimental	8 sessions of rehabilitation by effort in sports medicine	Behavioral: rehabilitation by effort

Interventions

Name	Type	Description	Arm Group Labels	Other Names
rehabilitation by effort	Behavioral		rehabilitation by effort

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
patients who completed at least 6 sessions of rehabilitation	number of patients who completed at least 6 sessions of rehabilitation by effort	10 years

Secondary Outcomes

Not provided

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

General condition according to World Health Organisation 0-1
Age between 18 and 70 years old
Non progressive patients according to RECIST criteria 1.1 after chemotherapy treatment whichever line of treatment
Autonomous patient
Voluntary written informed consent signed
Patients with social security insurance

Exclusion Criteria:

Bone metastasis with fracture risk
Significant cardiovascular pathology
Cardiac, vascular, rheumatologic or neurologic contraindication
Patients living far 60 kms from Toulouse
Patients under juridical protection guardianship, or tutelage measure

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

70 Years

Standard Ages

AdultOlder Adult

Study Population

Not provided

Sampling Method

Not provided

Contacts/Locations Module

Central Contacts

Not provided

Overall Officials

Name	Affiliation	Role
Julien Mazières, MD PhD	University Hospital, Toulouse	Principal Investigator

Locations

Facility	Status	City	State	ZIP	Country	Contacts
CHU de Toulouse		Toulouse	France	31059	France

Condition Browse Module

MeSH Terms

ID	Term
D002283	Carcinoma, Bronchogenic
D000086002	Mesothelioma, Malignant

Ancestor Terms

ID	Term
D001984	Bronchial Neoplasms
D008175	Lung Neoplasms
D012142	Respiratory Tract Neoplasms
D013899	Thoracic Neoplasms

Browse Leaves

Not provided

Browse Branches

Not provided